News

# Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness

#
Johnson & Johnson pauses coronavirus vaccine trials after unexplained illness

Such pauses not uncommon; ‘careful review’ to take place before late-stage study resumes

A woman receives an injection during phase 3 testing for the Johnson & Johnson vaccine candidate.


Johnson & Johnson via AP

Johnson & Johnson has paused clinical trials for its COVID-19 vaccine candidate after an unexplained illness by a participant

The drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and enrollment has been halted, citing  “an unexplained illness in a study participant.”

J&J
JNJ,
+0.57%
noted that such pauses “are not uncommon in clinical trials,” and said there would be “a careful review of all of the medical information before deciding whether to restart the study.”

Rival AstraZeneca
AZN,
+1.00%
paused the late-stage trials of its coronavirus vaccine candidate in early September after an unexplained illness by a participant in the U.K. Regulators in the U.K., Brazil, India and South Africa have since allowed AstraZeneca’s trials to resume, though it remains on hold in the U.S. as the Food and Drug Administration has widened its investigation.

There are seven coronavirus candidates being tested in the U.S., with at least four moving to late-stage trials.

Johnson & Johnson shares are up 4% year to date, compared to the S&P 500’s
SPX,
+1.64%
9% gain.

For forums sites go to Forum.BuradaBiliyorum.Com

If you want to read more News articles, you can visit our News category.

Source

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Please allow ads on our site

Please consider supporting us by disabling your ad blocker!